The -13.88% Decline of Nasdaq Inc’s (NDAQ) Stock in the Past Quarter

The stock of Nasdaq Inc (NDAQ) has seen a -1.35% decrease in the past week, with a 2.56% gain in the past month, and a 22.75% flourish in the past quarter. The volatility ratio for the week is 1.35%, and the volatility levels for the past 30 days are at 1.61% for NDAQ. The simple moving average for the past 20 days is 0.24% for NDAQ’s stock, with a 18.01% simple moving average for the past 200 days.

Is It Worth Investing in Nasdaq Inc (NASDAQ: NDAQ) Right Now?

Nasdaq Inc (NASDAQ: NDAQ) has a higher price-to-earnings ratio of 41.95x compared to its average ratio, The 36-month beta value for NDAQ is at 0.96. Analysts have varying views on the stock, with 6 analysts rating it as a “buy,” 0 rating it as “overweight,” 6 as “hold,” and 1 as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for NDAQ is 326.17M, and currently, shorts hold a 1.68% of that float. The average trading volume for NDAQ on October 01, 2024 was 2.95M shares.

NDAQ) stock’s latest price update

Nasdaq Inc (NASDAQ: NDAQ)’s stock price has gone rise by 0.56 in comparison to its previous close of 72.60, however, the company has experienced a -1.35% decrease in its stock price over the last five trading days. businesswire.com reported 2024-09-30 that REDWOOD CITY, Calif. & BOSTON–(BUSINESS WIRE)–Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted inducement awards on September 30, 2024. Four individuals were hired by Adicet in September 2024. In the aggregate, Adicet granted new hires non-qualified stock options to purchase 33,600 shares of Adicet’s common stock with an exercise price of $1.

Analysts’ Opinion of NDAQ

Many brokerage firms have already submitted their reports for NDAQ stocks, with RBC Capital Mkts repeating the rating for NDAQ by listing it as a “Outperform.” The predicted price for NDAQ in the upcoming period, according to RBC Capital Mkts is $88 based on the research report published on September 27, 2024 of the current year 2024.

TD Cowen, on the other hand, stated in their research note that they expect to see NDAQ reach a price target of $83. The rating they have provided for NDAQ stocks is “Hold” according to the report published on September 26th, 2024.

Oppenheimer gave a rating of “Outperform” to NDAQ, setting the target price at $80 in the report published on September 09th of the current year.

NDAQ Trading at 4.43% from the 50-Day Moving Average

After a stumble in the market that brought NDAQ to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -2.49% of loss for the given period.

Volatility was left at 1.61%, however, over the last 30 days, the volatility rate increased by 1.35%, as shares surge +1.29% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +16.80% upper at present.

During the last 5 trading sessions, NDAQ fell by -1.35%, which changed the moving average for the period of 200-days by +34.78% in comparison to the 20-day moving average, which settled at $72.88. In addition, Nasdaq Inc saw 25.58% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at NDAQ starting from Zecca John, who sale 11,000 shares at the price of $71.97 back on Sep 12 ’24. After this action, Zecca John now owns 113,263 shares of Nasdaq Inc, valued at $791,670 using the latest closing price.

JOHN ZECCA, the Officer of Nasdaq Inc, proposed sale 11,000 shares at $71.98 during a trade that took place back on Sep 12 ’24, which means that JOHN ZECCA is holding shares at $791,761 based on the most recent closing price.

Stock Fundamentals for NDAQ

Current profitability levels for the company are sitting at:

  • 0.26 for the present operating margin
  • 0.68 for the gross margin

The net margin for Nasdaq Inc stands at 0.14. The total capital return value is set at 0.08. Equity return is now at value 11.05, with 3.39 for asset returns.

Based on Nasdaq Inc (NDAQ), the company’s capital structure generated 0.47 points at debt to capital in total, while cash flow to debt ratio is standing at 0.17. The debt to equity ratio resting at 0.9. The interest coverage ratio of the stock is -171.1.

Currently, EBITDA for the company is 1.44 billion with net debt to EBITDA at 5.22. When we switch over and look at the enterprise to sales, we see a ratio of 7.89. The receivables turnover for the company is 6.84for trailing twelve months and the total asset turnover is 0.22.

Conclusion

In conclusion, Nasdaq Inc (NDAQ) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts